Director – Clinical Operations

Cornerstone is looking to increase its breadth through co-development, partnering, and acquisitions in addition to developing its lead Cancer Metabolic molecule CPI-613® (devimistat). The Director of Clinical Operations at Cornerstone will lead the execution of global and/or local oncology phase 1-3 clinical studies, programs, or franchises in adherence to GCPs, appropriate SOPs, FDA regulations/EU Directive, and ICH guidelines.